The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
WIN 2013 Symposium “Personalized Cancer Therapy: From Innovation to Implementation”
The WIN 2013 Symposium is the fifth in an annual series of multi-sector, worldwide Symposia dedicated to the advancement of personalized cancer medicine. The theme of WIN2013, taking place July 10-12, 2013, in Paris, France, is:
“Personalized Cancer Therapy: From Innovation to Implementation”
Join leaders from around the world in a collaborative, global forum to learn about and share innovations that represent the most promising advances in personalized cancer care. Globally-recognized experts from academia, pharma, life-sciences, healthcare IT, regulatory, and patient advocacy will present in plenary sessions on:
-
OMICS assays that support personalized clinical care today
Moderator: Alexander Eggermont, Institut Gustave Roussy (France) -
Analysis and clinical application of genomics
Moderator: Levi Garraway, Dana-Farber Cancer Institute (USA) -
Clinical progress in personalized cancer therapy
Moderator: Richard L. Schilsky, ASCO (USA) -
New approaches that impact personalized cancer care
Moderator: John Mendelsohn, MD Anderson Cancer Center (USA)
WIN2013 is a unique opportunity for all stakeholders in personalized cancer medicine. With extended time for discussion and interaction, the Symposium offers you opportunities to learn from, and network with, leaders from around the globe regarding the most transformational developments in cancer care.